Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Urinary Bladder

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...

Cholinergic Antagonists: Therapeutic Uses

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Selected Patients with Benign Prostatic Enlargement and Detrusor Underactivity may Benefit from Prostate Surgery: An Exploratory Study.

Urology research & practice·2026

Same author

ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.

Clinical endocrinology·2026

Same author

Botulinum Toxin Type A Injections in the Bladder Wall-An Effective Treatment for Urinary Incontinence with Low Long-Term Adherence.

Toxins·2026

Same author

Have I seen you before? Evaluating the learning of naturalistic faces and faces in art.

Neuropsychologia·2026

Same author

Women with chronic pelvic pain can be stratified using multimodal assessment.

Pain·2026

Same author

Are we ready to explore administration of botulinum toxin in the management of male sexual dysfunctions?

The journal of sexual medicine·2026

Search research articles

Related Experiment Video

Updated: May 11, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Botulinum toxin treatment for bladder dysfunction.

André Santos-Silva¹, Carlos Martins da Silva, Francisco Cruz

¹Department of Urology, Faculty of Medicine and Hospital de São João, Porto, Portugal.

International Journal of Urology : Official Journal of the Japanese Urological Association

|May 3, 2013

Summary

This summary is machine-generated.

Onabotulinum toxin A effectively treats urinary incontinence from overactive bladder and neurogenic detrusor overactivity. Repeated treatments are necessary for sustained symptom relief and improved quality of life.

Keywords:

botulinum toxin neurogenic detrusor overactivity onabotulinum toxin A overactive bladder urinary incontinence

More Related Videos

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

Related Experiment Videos

Last Updated: May 11, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

Area of Science:

Urology
Neurology
Pharmacology

Background:

Onabotulinum toxin A is a leading treatment for overactive bladder (OAB) and neurogenic detrusor overactivity (NDO).
Different botulinum toxin A complexes exist, but onabotulinumtoxinA is the most studied for urinary incontinence.

Purpose of the Study:

To review the efficacy and safety of onabotulinumtoxinA for treating urinary incontinence in patients with NDO and idiopathic OAB.
To establish appropriate dosing and administration guidelines for onabotulinumtoxinA in these patient populations.

Main Methods:

Systematic review of studies evaluating onabotulinumtoxinA for NDO and OAB.
Analysis of efficacy in reducing urinary incontinence, improving quality of life, and bladder function.
Assessment of adverse events and patient outcomes.

Main Results:

OnabotulinumtoxinA (200 U for NDO, 100 U for OAB) significantly reduces incontinence, improves quality of life, and increases bladder capacity.
Treatment effects are independent of anticholinergic use.
Adverse events are generally mild, including UTIs and temporary urinary retention.

Conclusions:

OnabotulinumtoxinA is a safe and effective treatment for NDO and OAB, offering sustained benefits with repeated injections.
Patients require counseling regarding the transient nature of the treatment and the need for repeat procedures.